Join Free
SI Premium
RSS Feeds
E-mail Alerts
Portfolio
Login
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Indicators
DJI
Nasdaq Composite
SPX
Gold
Crude Oil
Markets
Stocks
ETFs
Tools
Overview
News
Currencies
International
Treasuries
Gilead Sciences
(NQ:
GILD
)
67.60
+0.31 (+0.46%)
Streaming Delayed Price
Updated: 11:04 AM EDT, May 22, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Headline News about Gilead Sciences
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
30
31
Next >
$1000 Invested In This Stock 20 Years Ago Would Be Worth $11,000 Today
June 22, 2023
Via
Benzinga
Alleged Industrial Espionage Makes an Interesting Story
June 21, 2023
We also chat about Vertex Pharmaceuticals and its role at the center of cystic fibrosis treatment.
Via
The Motley Fool
2 Biotech Stocks You Can Buy and Hold for the Next Decade
June 21, 2023
Gilead and Regeneron Pharmaceuticals both had triple-digit percentage growth over the past decade.
Via
The Motley Fool
Arcellx, A Top 5% Biotech, Dives After A 'Perfect Storm' Leads To A Patient's Death
June 20, 2023
A patient died in Arcellx's multiple myeloma drug study. But the underlying factors are complex.
Via
Investor's Business Daily
Arcellx's Lead Product Candidate Hit By FDA Clinical Hold For Multiple Myeloma, Stock Falls
June 20, 2023
The FDA has put a clinical hold on Arcellx Inc's (NASDAQ: ACLX) iMMagine-1 Phase 2 clinical program for CART-ddBCMA investigational new drug for
Via
Benzinga
Here's How Much $1000 Invested In Gilead Sciences 20 Years Ago Would Be Worth Today
June 06, 2023
Via
Benzinga
A Look Into Gilead Sciences' Debt
May 16, 2023
Via
Benzinga
Looking Into Gilead Sciences's Recent Short Interest
May 12, 2023
Via
Benzinga
Gilead Sciences Stock: Bear vs. Bull
May 12, 2023
The S&P 500 has outperformed Gilead over the past five years.
Via
The Motley Fool
How to Retire Rich: Biotech Stocks Edition
June 18, 2023
Thanks to its enormous and practically permanent relevancies, the biotech sector offers a great avenue for retirement planning stocks.
Via
InvestorPlace
5 Stocks to Buy With Explosive 500% Potential
June 12, 2023
Take advantage of a bullish change in investor sentiment with these five stocks to buy for 500% upside potential.
Via
InvestorPlace
10 Health Care Stocks With Whale Alerts In Today's Session
June 09, 2023
Via
Benzinga
2 Top Biotech Stocks to Buy in June
June 09, 2023
Both companies have solid therapy franchises and continue to expand their horizons.
Via
The Motley Fool
3 Biotech Stocks That Could Skyrocket in the Next 12 Months
June 07, 2023
These promising biotech stocks are risky but offer tremendous upside generating stellar long-term returns in the upcoming 12 months.
Via
InvestorPlace
ImmunoGen, Day One Surge On Cancer Drug Updates, But Arcus Crashes
June 05, 2023
ImmunoGen and Day One gained Monday on their updates at a cancer treatment conference.
Via
Investor's Business Daily
3 Dividend Stocks You Can Buy Without Any Hesitation
June 03, 2023
The choices are easy with these stocks.
Via
The Motley Fool
The Biotech Buying Bonanza: Why The FTC's Amgen Battle Won't Chill The Spree
June 02, 2023
Big Pharma is facing a patent cliff that could siphon off billions in revenue.
Via
Investor's Business Daily
3 Undervalued Biotech Stocks to Buy Before They Blast Off
June 02, 2023
Fundamental analysis makes these three undervalued biotech stocks to buy plus they have other catalysts that make them compelling.
Via
InvestorPlace
Stocks Going Ex-Dividend In June 2023
May 27, 2023
The following is a short list of some of the many stocks going ex-dividend during the next month, which can be helpful for traders and investors interested in the stock trading technique known as...
Via
Talk Markets
10 Health Care Stocks Whale Activity In Today's Session
May 26, 2023
Via
Benzinga
Arcus Biosciences Soars On Roche's 'Meaningful' Results In A New Cancer Drug Class
May 26, 2023
Roche tested its treatment in patients with liver cancer and found "meaningful" results.
Via
Investor's Business Daily
Gilead Sciences Stock Reaches 80-Plus Relative Strength Rating Benchmark
May 25, 2023
On Thursday, Gilead Sciences stock had its Relative Strength (RS) Rating upgraded to 81, up from 78 a day earlier.
Via
Investor's Business Daily
3 Relatively Safe Stocks to Buy if a Recession Is on the Way
May 20, 2023
If the economy falters, these stocks should hold up better than most.
Via
The Motley Fool
3 Analyst Upgrades That Smart Investors Won’t Ignore
May 17, 2023
In many cases, analyst upgrades can point investors to opportunities like the ones in the stocks on this list.
Via
InvestorPlace
GDC Stock Alert: Why Is GD Culture Group Up 106% Today?
May 16, 2023
GD Culture (GDC) stock is rocketing higher on Tuesday with investors reacting to the company's earnings report for Q1 2023.
Via
InvestorPlace
Benzinga's Top Ratings Upgrades, Downgrades For May 16, 2023
May 16, 2023
Via
Benzinga
Why Is Guardforce AI (GFAI) Stock Up Today?
May 16, 2023
Guardforce AI (GFAI) stock is on the rise Tuesday after the AI company announced the closing of a public share offering.
Via
InvestorPlace
GILD Stock Price Predictions: Is Gilead Sciences Really Worth $100?
May 16, 2023
Gilead Sciences (GILD) stock is a hot topic on Tuesday as a new price target predicts a roughly 28% upside for the shares.
Via
InvestorPlace
Gilead Sciences To Rally Around 28%? Here Are 10 Other Analyst Forecasts For Tuesday
May 16, 2023
Morgan Stanley raised the price target for DraftKings Inc. (NASDAQ: DKNG) from $23 to $25. Morgan Stanley analyst Stephen Grambling maintained an Overweight rating. DraftKings shares fell 0.2% to close...
Via
Benzinga
10 Health Care Stocks With Whale Alerts In Today's Session
May 09, 2023
Via
Benzinga
< Previous
1
2
...
6
7
8
9
10
11
12
13
14
...
30
31
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.